Doctors see the potential in the use of options cord blood stem cells viable for therapy in a growing list of diseases and conditions. Cord blood is currently used as an optional form of therapy to 75 illnesses and fatal diseases.
Researchers continue to perform medical tests test the viability of cord blood in various blood diseases and medical conditions. There are a number of benchmarks that experts continue to off bank:
· Cord blood is known as a rich source of hematopoietic stem cells
· Blood cord is in the placenta and umbilical cord of newborns
· cord blood is collected without risk to the health of the mother or the newborn
· stem cells cord blood have been used in over 20,000 transplants worldwide
· Unlike bone marrow, cord blood does not need to be an exact genetic match between donor and recipient
cord blood is most often used to improve the lives of patients with leukemia, lymphoma and other blood or bone marrow diseases. But the researchers believe that there are more opportunities to use the cord blood as a source for therapy of autoimmune diseases, including type 1 diabetes, MS or cerebral palsy.
Much of this research is conducted with cord blood samples stored in banks given public donors across much of the world. But researchers believe that if clinical trials are successful, these successes result in a greater need and use to the marrow family private blood banks that store cord blood samples for specific needs of each family.
As doctors conduct more clinical trials, the results could highlight the increased benefits from cells cord blood stem and increase the need for confidence cord blood banks.